Bristol-Myers Squibb - Company & Market Research Reports

Home /
Companies /
Bristol-Myers Squibb

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 464
Immune Disorders Drugs 194
Cardiovascular Drugs 153
Biopharmaceuticals 131
Infectious Diseases Drugs 121
Central Nervous System Drugs 104
Drug Discovery 102
Endocrine and Metabolic Disorders Drugs 102
Musculoskeletal Disorders Drugs 93
Clinical Trials 90
Pharmaceuticals 89
Leukemia Drugs 82
Hematological Drugs 81
Liver and Kidney Disorders Drugs 74
Lymphoma Drugs 64
Dermatological Drugs 58
Diabetes Drugs 54
Skin Cancer Drugs 50
Brain Cancer Drugs 47
Mental Disorders Drugs 41
Lung Cancer Drugs 40
Respiratory Drugs 38
Immunosuppressive Drugs 36
Gastrointestinal Drugs 34
Drug Delivery 32
Infusions and Injectables 31
Pharmaceutical Intermediates 30
Liver Cancer Drugs 30
Pharmaceutical Manufacturing 27
Analgesics 26
Bladder Cancer Drugs 25
Drugs by Therapeutic Area 23
Kidney Cancer Drugs 22
Antibiotics 22
HIV/AIDS Drugs 22
Breast Cancer Drugs 18
Ovarian Cancer Drugs 17
Colon Cancer Drugs 17
Cervical Cancer Drugs 17
Pancreatic Cancer Drugs 17
Psoriasis Drugs 17
Prostate Cancer Drugs 16
Urological Disorders Drugs 16
Schizophrenia Drugs 15
Thyroid Cancer Drugs 14
Sexual and Reproductive Health Drugs 14
Cancer Vaccines 13
Over the Counter (OTC) Drugs 12
Biosimilars and Biosuperiors 10
Optical Disorders Drugs 8
Generic Drugs 8
Alzheimer's Disease Drugs 8
Transdermal and Transmucosal Drug Delivery 7
Vaccines 7
Uterine Cancer Drugs 7
Cough and Cold Drugs 6
Anti-Obesity Drugs 6
Anxiety Drugs 6
Company Reports 5
Pharmacoeconomics 3
Vitamins and Dietary Supplements 3
Addiction Disorders Drugs 2
Animal Pharmaceuticals 2
Asthma Drugs 2
Inhalers and Nebulisers 1
Anesthetic Drugs 1
Allergy Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



281 reviews

2,376 Results (Page 103 of 119)
- Relevance
  Sort by

Japan Oral Anti-Diabetic Drug - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

 Report
February 2024
70 Pages
Japan

From

€4194EUR$4,750USD£3,623GBP

Italy Oral Anti-Diabetic Drug - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

 Report
February 2024
70 Pages
Italy

From

€4194EUR$4,750USD£3,623GBP

India Oral Anti-Diabetic Drug - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

 Report
February 2024
70 Pages
India

From

€4194EUR$4,750USD£3,623GBP

Brazil Anti-Rheumatic Drug Market - Forecasts from 2022 to 2027

 Report
September 2022
76 Pages
Brazil

From

€2958EUR$3,350USD£2,555GBP

France Anti-Rheumatic Drug Market - Forecasts from 2022 to 2027

 Report
September 2022
77 Pages
France

From

€2958EUR$3,350USD£2,555GBP

NEED HELP FINDING THE RIGHT PRODUCT? Brian will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Germany Anti-Rheumatic Drug Market - Forecasts from 2022 to 2027

 Report
September 2022
75 Pages
Germany

From

€2958EUR$3,350USD£2,555GBP

Israel Anti-Rheumatic Drug Market - Forecasts from 2022 to 2027

 Report
September 2022
76 Pages
Israel

From

€2958EUR$3,350USD£2,555GBP

Turkey Anti-Rheumatic Drug Market - Forecasts from 2022 to 2027

 Report
September 2022
82 Pages
Turkey

From

€2958EUR$3,350USD£2,555GBP

TYK2 Kinase Inhibitors - Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€1325EUR$1,500USD£1,144GBP

Next Generation Antibody Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

 Report
January 2024
106 Pages
Global

€4411EUR$4,995USD£3,810GBP

Autoimmune Disorders Drugs Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application

 Report
January 2025
135 Pages
Global

From

€3500EUR$4,246USD£3,129GBP

Anxiety Disorders & Depression Treatment Global Market Insights 2023, Analysis and Forecast to 2028, by Market Participants, Regions, Technology, Application, Product Type

 Report
May 2023
119 Pages
Global

From

€3500EUR$4,246USD£3,129GBP

Sphingosine 1 Phosphate Receptor Modulators - Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€1325EUR$1,500USD£1,144GBP

Notch Receptor Antagonists - Pipeline Insight, 2025

 Drug Pipelines
April 2025
60 Pages
Global

From

€1325EUR$1,500USD£1,144GBP

CD137 Agonist Antibody - Pipeline Insight, 2025

 Drug Pipelines
April 2025
60 Pages
Global

From

€1325EUR$1,500USD£1,144GBP

Oropharyngeal Cancer - Pipeline Insight, 2025

 Clinical Trials
April 2025
50 Pages
Global

From

€1325EUR$1,500USD£1,144GBP

Nasopharyngeal Cancer Market Report: Trends, Forecast and Competitive Analysis to 2030

 Report
September 2024
150 Pages
Global

From

€4283EUR$4,850USD£3,699GBP

Notch Signaling Pathway Inhibitor - Pipeline Insight, 2025

 Clinical Trials
April 2025
90 Pages
Global

From

€1325EUR$1,500USD£1,144GBP

Israel ischemic heart disease (IHD) Drugs Market Competition, Forecast and Opportunities, 2028

 Report
September 2023
83 Pages
Israel

From

€3091EUR$3,500USD£2,670GBP

T-cell Surface Glycoprotein CD4 - Pipeline Insight, 2025

 Clinical Trials
April 2025
90 Pages
Global

From

€1325EUR$1,500USD£1,144GBP

2,376 Results (Page 103 of 119)
- 1
- 101
- 102
- 103
- 104
- 105

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.